ICD-10 Coding for Immune Thrombocytopenia(D69.3, D69.3B, D69.3I)
Learn about ICD-10 coding for immune thrombocytopenia, including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Immune Thrombocytopenia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D69.3 | Immune thrombocytopenic purpura | Use when primary immune thrombocytopenia is confirmed by exclusion of secondary causes. |
|
| D69.5 | Secondary thrombocytopenia | Use when thrombocytopenia is secondary to another condition. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutImmune Thrombocytopenia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Immune Thrombocytopenia.
Vague documentation of thrombocytopenia
Impact
Clinical: Leads to misdiagnosis and inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims due to insufficient documentation.
Mitigation
Ensure detailed documentation of lab results and exclusion of other causes.
Using D69.3 for drug-induced thrombocytopenia
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use D69.5 with T45.1X5A for adverse effect.
Incorrect use of D69.3
Impact
Using D69.3 without excluding secondary causes.
Mitigation
Ensure thorough documentation of exclusion criteria.